Gerhardt Hindricks

Gerhardt Hindricks's AcademicInfluence.com Rankings

Gerhardt Hindricks

Medical

#1343

World Rank

#1670

Historical Rank

Cardiology

#94

World Rank

#96

Historical Rank

medical Degrees

Gerhardt Hindricks

Philosophy

#4325

World Rank

#6799

Historical Rank

Logic

#1813

World Rank

#2656

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Gerhardt Hindricks's Degrees

Doctorate Medicine University of Medicine, Taunggyi

Why Is Gerhardt Hindricks Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gerhardt Hindricks's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). (2018) (6316)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (4929)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (4672)
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) (4221)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. (2012) (3704)
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010) (3518)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). (2020) (3378)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. (2012) (3356)
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. (2016) (2621)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (2451)
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. (2012) (2260)
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. (2017) (1930)
Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. (2014) (1052)
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task F (2012) (1046)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017) (1010)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017) (986)
2018 ESC Guidelines for the diagnosis and management of syncope (2018) (942)
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial (2019) (800)
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. (2015) (729)
[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.] (2018) (669)
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019) (630)
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. (2020) (626)
Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420] (2011) (570)
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial (2014) (556)
European Society of Cardiology: Cardiovascular Disease Statistics 2019. (2019) (529)
Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence (2005) (488)
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (2016) (478)
The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. (2012) (437)
Tailored Atrial Substrate Modification Based on Low-Voltage Areas in Catheter Ablation of Atrial Fibrillation (2014) (411)
Performance of a New Leadless Implantable Cardiac Monitor in Detecting and Quantifying Atrial Fibrillation Results of the XPECT Trial (2010) (407)
Venice Chart International Consensus Document on Atrial Fibrillation Ablation (2007) (384)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary (2017) (345)
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design (2012) (319)
A novel radiofrequency ablation catheter using contact force sensing: Toccata study. (2012) (299)
Outcomes in Catheter Ablation of Ventricular Tachycardia in Dilated Nonischemic Cardiomyopathy Compared With Ischemic Cardiomyopathy: Results From the Prospective Heart Centre of Leipzig VT (HELP-VT) Study (2014) (297)
Complications of Atrial Fibrillation Ablation in a High‐Volume Center in 1,000 Procedures: Still Cause for Concern? (2009) (290)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary (2017) (261)
A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association (2017) (249)
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. (2012) (246)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary (2017) (244)
Catheter Ablation of Recurrent Scar‐Related Ventricular Tachycardia Using Electroanatomical Mapping and Irrigated Ablation Technology: Results of the Prospective Multicenter Euro‐VT‐Study (2010) (243)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. (2017) (242)
Regional Myocardial Sympathetic Dysinnervation in Arrhythmogenic Right Ventricular Cardiomyopathy: An Analysis Using 123I‐Meta‐Iodobenzylguanidine Scintigraphy (1994) (235)
Multicenter Outcomes for Catheter Ablation of Idiopathic Premature Ventricular Complexes. (2015) (234)
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. (2016) (229)
EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. (2016) (225)
Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. (2010) (217)
Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? (2004) (214)
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. (2020) (186)
The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. (2014) (184)
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. (2008) (182)
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. (2019) (166)
Specific linear left atrial lesions in atrial fibrillation: intraoperative radiofrequency ablation using minimally invasive surgical techniques. (2002) (166)
Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry (2017) (164)
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation (2018) (161)
Thermal Esophageal Lesions After Radiofrequency Catheter Ablation of Left Atrial Arrhythmias (2010) (158)
Circumferential pulmonary vein isolation and linear left atrial ablation as a single-catheter technique to achieve bidirectional conduction block: the pace-and-ablate approach. (2010) (152)
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). (2015) (149)
Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. (2010) (146)
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE (2017) (141)
Intraoperative Radiofrequency Ablation of Chronic Atrial Fibrillation: A Left Atrial Curative Approach by Elimination of Anatomic “Anchor” Reentrant Circuits (1999) (134)
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. (2016) (132)
Electromagnetic Versus Fluoroscopic Mapping of the Inferior Isthmus for Ablation of Typical Atrial Flutter: A Prospective Randomized Study (2000) (132)
Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. (2003) (131)
Radiofrequency coagulation of ventricular myocardium: improved prediction of lesion size by monitoring catheter tip temperature. (1989) (131)
ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association. (2012) (129)
The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation (2014) (129)
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. (2015) (128)
Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? (2013) (127)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017) (124)
Late recurrent arrhythmias after ablation of atrial fibrillation: incidence, mechanisms, and treatment. (2004) (122)
Outflow tract tachycardia with R/S transition in lead V3: six different anatomic approaches for successful ablation. (2005) (122)
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope (2018) (121)
Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score. (2015) (117)
Guidelines for the management of atrial fibrillation (Europace (2010) 12, (1360-1420)) (2011) (111)
Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized study (2018) (111)
Value of Different Follow‐Up Strategies to Assess the Efficacy of Circumferential Pulmonary Vein Ablation for the Curative Treatment of Atrial Fibrillation (2005) (106)
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2012) (105)
Incidental and ablation-induced findings during upper gastrointestinal endoscopy in patients after ablation of atrial fibrillation: a retrospective study of 425 patients. (2014) (104)
Electroanatomic reconstruction of the left atrium, pulmonary veins, and esophagus compared with the "true anatomy" on multislice computed tomography in patients undergoing catheter ablation of atrial fibrillation. (2006) (104)
The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation (2020) (103)
‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747] (2013) (103)
Venice Chart International Consensus Document on Ventricular Tachycardia/Ventricular Fibrillation Ablation (2010) (103)
Steerable Versus Nonsteerable Sheath Technology in Atrial Fibrillation Ablation: A Prospective, Randomized Study (2011) (102)
[2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS]. (2016) (101)
Rapid Detection and Successful Treatment of Esophageal Perforation After Radiofrequency Ablation of Atrial Fibrillation: Lessons from Five Cases (2006) (101)
:Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up. (2010) (100)
Coagulation of Ventricular Myocardium Using Radiofrequency Alternating Current: Bio‐Physical Aspects and Experimental Findings (1989) (99)
Topographic Variability of the Esophageal Left Atrial Relation Influencing Ablation Lines in Patients with Atrial Fibrillation (2005) (98)
Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST) (2017) (98)
P-wave evidence as a method for improving algorithm to detect atrial fibrillation in insertable cardiac monitors. (2014) (97)
Clinical Implications of Various Follow Up Strategies After Catheter Ablation of Atrial Fibrillation (2007) (97)
Polycystic disease of the kidneys complicating the diagnosis of myocardial echinococcosis. (1993) (97)
Effects of Sex on the Incidence of Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation: Results From a Worldwide Survey in 34 943 Atrial Fibrillation Ablation Procedures (2014) (95)
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference (2018) (94)
Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial. (2019) (94)
Idiopathic Left Ventricular Tachycardia: New Insights, into Electrophysiological Characteristics and Radiofrequency Catheter Ablation (1995) (94)
Deep Sedation for Catheter Ablation of Atrial Fibrillation: A Prospective Study in 650 Consecutive Patients (2011) (93)
Common Genetic Variants and Response to Atrial Fibrillation Ablation (2015) (91)
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? (2018) (90)
Automatic home monitoring of implantable cardioverter defibrillators. (2008) (90)
MRI Assessment of Ablation‐Induced Scarring in Atrial Fibrillation: Analysis from the DECAAF Study (2015) (90)
Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc Scores for the Prediction of Rhythm Outcomes After Catheter Ablation of Atrial Fibrillation: The Leipzig Heart Center AF Ablation Registry (2014) (88)
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. (2019) (87)
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication☆☆☆ (2016) (86)
Effect of Electroanatomically Guided Versus Conventional Catheter Ablation of Typical Atrial Flutter on the Fluoroscopy Time and Resource Use: A Prospective Randomized Multicenter Study (2009) (85)
Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. (2004) (85)
A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice. (2013) (81)
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2016) (81)
Venice Chart International Consensus Document on Atrial Fibrillation Ablation: 2011 Update (2012) (81)
State of the art of leadless pacing (2015) (81)
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2017) (79)
Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association. (2016) (78)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (77)
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. (2016) (76)
Successful Repeat Catheter Ablation of Recurrent Longstanding Persistent Atrial Fibrillation With Rotor Elimination as the Procedural Endpoint: A Case Series (2016) (76)
Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis. (2011) (76)
Feasibility of real-time magnetic resonance imaging-guided electrophysiology studies in humans. (2013) (76)
Simultaneous Noncontact Mapping of Left Atrium in Patients With Paroxysmal Atrial Fibrillation (2001) (75)
Impact of radiofrequency catheter ablation of accessory pathways on the frequency of atrial fibrillation during long-term follow-up; high recurrence rate of atrial fibrillation in patients older than 50 years of age. (2001) (73)
Three‐Dimensional Electromagnetic Catheter Technology: (1997) (73)
Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysis (2011) (73)
Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. (1994) (72)
Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial (2016) (71)
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial. (2015) (71)
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency (2016) (71)
Early Referral for Ablation of Scar-Related Ventricular Tachycardia Is Associated With Improved Acute and Long-Term Outcomes: Results From the Heart Center of Leipzig Ventricular Tachycardia Registry (2014) (71)
Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control. (2014) (70)
CMR-Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis: The Importance of Coexisting Myocardial Inflammation. (2017) (69)
Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial (2013) (69)
Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry (2016) (68)
Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association. (2015) (67)
Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration. (2005) (65)
Real-time magnetic resonance-guided ablation of typical right atrial flutter using a combination of active catheter tracking and passive catheter visualization in man: initial results from a consecutive patient series. (2016) (64)
Novel Measure of Local Impedance Predicts Catheter–Tissue Contact and Lesion Formation (2018) (63)
Characteristics of local electrogram predicting successful transcatheter radiofrequency ablation of left-sided accessory pathways. (1992) (62)
Catheter ablation of atrial fibrillation using remote magnetic catheter navigation: a case-control study. (2011) (62)
Radiofrequency Catheter Ablation of Ventricular Tachycardia Following Implantation of an Automatic Cardioverter Defibrillator (1993) (61)
Catheter Ablation of Electrical Storm Due to Monomorphic Ventricular Tachycardia in Patients with Nonischemic Cardiomyopathy: Acute Results and Its Effect on Long‐Term Survival (2010) (61)
Catheter Ablation of Ventricular Tachycardia and Mortality in Patients With Nonischemic Dilated Cardiomyopathy: Can Noninducibility After Ablation Be a Predictor for Reduced Mortality? (2015) (60)
Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak Insights from the German-wide Helios hospital network (2020) (60)
Quantitative Analysis of Isolation Area and Rhythm Outcome in Patients With Paroxysmal Atrial Fibrillation After Circumferential Pulmonary Vein Antrum Isolation Using the Pace-and-Ablate Technique (2012) (59)
Cardiac tamponade in catheter ablation of atrial fibrillation: German-wide analysis of 21 141 procedures in the Helios atrial fibrillation ablation registry (SAFER) (2018) (58)
Cardiología (ESC) Desarrolladas con la contribución especial de European Heart Rhythm Association (EHRA) Aprobado por European Association for Cardio-Thoracic Surgery (EACTS) (2010) (58)
Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation. (2013) (58)
Color-coded three-dimensional entrainment mapping for analysis and treatment of atrial macroreentrant tachycardia. (2009) (56)
MR imaging-guided electrophysiological ablation studies in humans with passive catheter tracking: initial results. (2014) (56)
Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation. (2014) (56)
Catheter Ablation of Ventricular Tachycardia in Remote Myocardial Infarction: (2003) (56)
Renal Dysfunction, Stroke Risk Scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the Risk of Thromboembolic Events After Catheter Ablation of Atrial Fibrillation: The Leipzig Heart Center AF Ablation Registry (2013) (55)
Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy. (2014) (54)
Successful Nonsurgical Treatment of Esophagopericardial Fistulas After Atrial Fibrillation Catheter Ablation: A Case Series (2013) (54)
Long‐Term Efficacy of Single Procedure Remote Magnetic Catheter Navigation for Ablation of Ischemic Ventricular Tachycardia: A Retrospective Study (2012) (54)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population (2020) (53)
Safety profile of near-zero fluoroscopy atrial fibrillation ablation with non-fluoroscopic catheter visualization: experience from 1000 consecutive procedures (2018) (53)
EnSite Velocity™ cardiac mapping system: a new platform for 3D mapping of cardiac arrhythmias (2010) (53)
In‐hospital care in acute heart failure during the COVID‐19 pandemic: insights from the German‐wide Helios hospital network (2020) (52)
In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures (2018) (52)
Galectin-3 in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation (2015) (52)
Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia. (2015) (51)
Corrigendum to: ‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747] (2013) (51)
Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery. (2014) (51)
Oesophageal Probe Evaluation in Radiofrequency Ablation of Atrial Fibrillation (OPERA): results from a prospective randomized trial. (2020) (50)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (49)
Quality indicators for the care and outcomes of adults with atrial fibrillation. (2020) (47)
Nonfluoroscopic Catheter Visualization in Atrial Fibrillation Ablation: Experience From 375 Consecutive Procedures (2014) (47)
Clinical Performance of the St. Jude Medical Riata Defibrillation Lead in a Large Patient Population (2010) (47)
Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN‐TIME study (2008) (46)
Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study (2016) (46)
Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: a device-dependent imaging strategy for improved image quality (2018) (46)
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe (2020) (45)
Acute and Long‐Term Clinical Outcome After Endoscopic Pulmonary Vein Isolation: Results from the First Prospective, Multicenter Study (2013) (45)
Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial. (2022) (44)
Antiarrhythmic surgery for treatment of atrial fibrillation--new concepts. (1999) (44)
First in Human Validation of Impedance‐Based Catheter Tip‐to‐Tissue Contact Assessment in the Left Atrium (2009) (44)
Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials. (2019) (44)
Initial Clinical Experience with a Remote Magnetic Catheter Navigation System for Ablation of Cavotricuspid Isthmus‐Dependent Right Atrial Flutter (2008) (43)
Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and meta-analysis (2019) (43)
Steerable Sheath Catheter Navigation for Ablation of Atrial Fibrillation: A Case‐Control Study (2008) (43)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (42)
Impact of Metabolic Syndrome on Left Atrial Electroanatomical Remodeling and Outcomes After Radiofrequency Ablation of Nonvalvular Atrial Fibrillation (2014) (42)
Ablation of Polymorphic Ventricular Tachycardias in Patients with Structural Heart Disease (2008) (41)
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial: clinical rationale, study design, and implementation. (2009) (41)
Initial Clinical Experience with the New Irrigated Tip Magnetic Catheter for Ablation of Scar‐Related Sustained Ventricular Tachycardia: A Small Case Series (2009) (41)
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. (2015) (41)
Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment (2018) (40)
Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation (2018) (40)
Ablation of Atrial Fibrillation Using Novel 4-Dimensional Catheter Tracking Within Autoregistered Left Atrial Angiograms (2012) (40)
Initial Experience With Ultra High‐Density Mapping of Human Right Atria (2016) (40)
Catheter Ablation of Scar‐Related Ventricular Tachycardia in Patients with Electrical Storm Using Remote Magnetic Catheter Navigation (2010) (39)
Long‐Term Impact of Right Ventricular Pacing on Left Ventricular Systolic Function in Pacemaker Recipients With Preserved Ejection Fraction: Results From a Large Single‐Center Registry (2016) (39)
Initial experience in ablation of typical atrial flutter using a novel three-dimensional catheter tracking system. (2013) (39)
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664]. (2017) (39)
The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial. (2018) (38)
Nonfluoroscopic sensor-guided navigation of intracardiac electrophysiology catheters within prerecorded cine loops. (2011) (38)
Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study (2018) (38)
Atrial Arrhythmias Following Surgical AF Ablation: Electrophysiological Findings, Ablation Strategies, and Clinical Outcome (2014) (38)
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force (2015) (38)
Cavotricuspid isthmus ablation guided by real-time magnetic resonance imaging. (2013) (37)
Left Ventricular Diastolic Dysfunction in Atrial Fibrillation: Predictors and Relation with Symptom Severity (2012) (37)
Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes. (2018) (37)
The APPLE Score – A Novel Score for the Prediction of Rhythm Outcomes after Repeat Catheter Ablation of Atrial Fibrillation (2017) (37)
ECG morphology of premature ventricular contractions predicts the presence of myocardial fibrotic substrate on cardiac magnetic resonance imaging in patients undergoing ablation (2017) (36)
Efficacy of LGE‐MRI‐guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design (2021) (36)
Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation (2017) (36)
Catheter ablation of atrial fibrillation supported by novel nonfluoroscopic 4D navigation technology. (2013) (35)
The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy. (2015) (35)
Contemporary Mapping Techniques of Complex Cardiac Arrhythmias - Identifying and Modifying the Arrhythmogenic Substrate. (2014) (34)
EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. (2019) (34)
Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany—An analysis of over 5 million patients (2018) (34)
European Society of Cardiology: Cardiovascular Disease Statistics 2019 (Executive Summary). (2020) (34)
Individually tailored left ventricular lead placement: lessons from multimodality integration between three-dimensional echocardiography and coronary sinus angiogram. (2013) (34)
Response of High-Sensitive C-Reactive Protein to Catheter Ablation of Atrial Fibrillation and Its Relation with Rhythm Outcome (2012) (34)
Atrial fibrillation ablation in heart failure (2018) (33)
Atrial Fibrillation and Cognitive Impairment: New Insights and Future Directions. (2019) (33)
Comparison of left atrial dimensions in CT and echocardiography as predictors of long-term success after catheter ablation of atrial fibrillation (2015) (33)
MediGuide in supraventricular tachycardia: initial experience from a multicentre registry. (2013) (33)
Computed tomography model-based treatment of atrial fibrillation and atrial macro-re-entrant tachycardia (2008) (32)
The Diagnosis and Treatment of Pacemaker-Associated Infection. (2018) (32)
Catheter ablation of ventricular tachycardia in patients with coronary heart disease. (1995) (32)
Cardiac Resynchronization Therapy Device Implantation Using a New Sensor-Based Navigation System: Results From the First Human Use Study (2013) (31)
Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies. (2014) (31)
Acquired Pulmonary Vein Stenosis After Radiofrequency Ablation for Atrial Fibrillation: Single-Center Experience in Catheter Interventional Treatment. (2018) (31)
Artefact-free late gadolinium enhancement imaging in patients with implanted cardiac devices using a modified broadband sequence: current strategies and results from a real-world patient cohort (2018) (31)
Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial. (2015) (31)
Insights from preclinical ultra high-density electroanatomical sinus node mapping. (2015) (30)
Clinical workflow and applicability of electrophysiological cardiovascular magnetic resonance-guided radiofrequency ablation of isthmus-dependent atrial flutter (2018) (30)
Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation? (2017) (30)
World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update (2021) (30)
Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials. (2009) (29)
Non-fluoroscopic catheter visualization using MediGuide™ technology: experience from the first 600 procedures (2014) (29)
Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction (2017) (29)
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. (2020) (29)
Advanced Mapping Systems To Guide Atrial Fibrillation Ablation: Electrical Information That Matters. (2016) (28)
First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial (2021) (28)
Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial (2016) (28)
Predictors of ventricular arrhythmia after left ventricular assist device implantation: A large single-center observational study. (2017) (28)
Trigger activity more than three years after left atrial linear ablation without pulmonary vein isolation in patients with atrial fibrillation. (2005) (28)
The predictive value of echocardiographic parameters associated with left ventricular diastolic dysfunction on short- and long-term outcomes of catheter ablation of atrial fibrillation. (2014) (28)
Electroanatomical mapping of atrial fibrillation: Review of the current techniques and advances. (2014) (27)
Differentiating atrioventricular nodal reentrant tachycardia from tachycardia via concealed accessory pathway. (2005) (27)
Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences (2014) (27)
Response of circulating heat shock protein 70 and anti-heat shock protein 70 antibodies to catheter ablation of atrial fibrillation (2013) (26)
Characteristics of PR interval as predictor for atrial fibrillation: association with biomarkers and outcomes (2017) (26)
Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number (2019) (26)
Radiofrequency ablation in children and adolescents: results in 154 consecutive patients. (2006) (26)
Procedural Outcomes and Survival After Catheter Ablation of Ventricular Tachycardia in Relation to Electroanatomical Substrate in Patients With Nonischemic‐Dilated Cardiomyopathy: The Role of Unipolar Voltage Mapping (2015) (25)
Radiofrequency Catheter Ablation of Idiopathic Left Ventricular Tachycardia: (1994) (25)
Genetic ACE I/D Polymorphism and Recurrence of Atrial Fibrillation After Catheter Ablation (2013) (25)
Patient discomfort following catheter ablation and rhythm device surgery. (2015) (25)
Prediction of electro-anatomical substrate using APPLE score and biomarkers (2018) (25)
Feasibility and Reliability of SmartWatch to Obtain 3-Lead Electrocardiogram Recordings (2020) (24)
Impact of left atrial appendage morphology on peri-interventional thromboembolic risk during catheter ablation of atrial fibrillation. (2014) (24)
Temperature-controlled slow pathway ablation for treatment of atrioventricular nodal reentrant tachycardia using a combined anatomical and electrogram guided strategy. (1996) (24)
Electrophysiology study guided by real-time magnetic resonance imaging. (2012) (24)
Recurrence and Late Block of Accessory Pathway Conduction Following Radiofrequency Catheter Ablation (1994) (24)
Atrial fibrillation: A review of modifiable risk factors and preventive strategies (2019) (23)
Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challengesCatheter ablation of atrial fibrillation: current status, techniques, outcomes, and challenges. (2018) (23)
Catheter Ablation Guided by Real-Time MRI (2014) (23)
Contemporary catheter ablation of arrhythmias in geriatric patients: patient characteristics, distribution of arrhythmias, and outcome. (2007) (22)
Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry (2015) (21)
Temporary left ventricular stimulation in patients with refractory cardiogenic shock and asynchronous left ventricular contraction: a safety and feasibility study. (2013) (21)
Differentiating the origin of outflow tract ventricular arrhythmia using a simple, novel approach. (2015) (21)
European cardiac resynchronization therapy survey II: rationale and design. (2015) (21)
Electrical storm in patients with implantable cardioverter-defibrillator in the era of catheter ablation: Implications for better rhythm control. (2015) (21)
Emergency hospital admissions for psychiatric disorders in a German-wide hospital network during the COVID-19 outbreak (2021) (21)
Cardiogenic Stroke Despite Low CHA2DS2‐VASc Score: Assessing Stroke risk by Left Atrial Appendage Anatomy (ASK LAA) (2015) (21)
Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation (2019) (21)
Radiation dose among different cardiac and vascular invasive procedures: The RODEO study. (2017) (21)
Asymmetrical left atrial remodelling in atrial fibrillation: relation with diastolic dysfunction and long-term ablation outcomes (2016) (21)
Radiofrequency Catheter Ablation of the Anterosuperior and Posteroinferior Atrial Approaches to the AV Node for Treatment of AV Nodal Reentrant Tachycardia (1997) (20)
Enhancement of intracardiac navigation by new GPS-guided location system (MediGuide Technologies). (2012) (20)
Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation (2018) (20)
Use of electrical coupling information in AF catheter ablation: a prospective randomized pilot study. (2013) (20)
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2017) (20)
Impact of asymmetrical dilatation of the left atrium on the long-term success after catheter ablation of atrial fibrillation. (2015) (20)
Efficacy of Ajmaline and Propafenone in Patients with Accessory Pathways: A Prospective Randomized Study (1994) (20)
Ablation of typical atrial flutter using a non-fluoroscopic catheter tracking system vs. conventional fluoroscopy--results from a prospective randomized study. (2015) (20)
Safety of Remote Magnetic Navigation in Patients With Pacemakers and Implanted Cardioverter Defibrillators (2010) (20)
Association of atrial fibrillation susceptibility genes, atrial fibrillation phenotypes and response to catheter ablation: a gene-based analysis of GWAS data (2017) (20)
Prevalence and predictors of worsened left ventricular diastolic dysfunction after catheter ablation of atrial fibrillation. (2013) (20)
Natriuretic peptides: biomarkers for atrial fibrillation management (2020) (20)
Sympathetic innervation of the left ventricle is impaired in arrhythmogenic right ventricular disease (1993) (19)
Rational and design of EuroCRT: an international observational study on multi-modality imaging and cardiac resynchronization therapy (2017) (19)
The role of implantable cardioverter defibrillators in dilated cardiomyopathy. (1994) (19)
Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation (2020) (19)
Cumulative hospitalization deficit for cardiovascular disorders in Germany during the Covid-19 pandemic (2020) (19)
Treatment of hypercholesterolaemia with PCSK9 inhibitors in patients after cardiac transplantation (2019) (19)
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014)) (2019) (19)
Catheter ablation of ventricular tachycardia using radiofrequency current. (1992) (19)
Ivabradine for rate control in atrial fibrillation. (2015) (19)
Catheter Ablation of Ischemic Ventricular Tachycardia With Remote Magnetic Navigation: STOP‐VT Multicenter Trial (2016) (19)
In‐hospital mortality in heart failure in Germany during the Covid‐19 pandemic (2020) (19)
Irrigated Tip Catheters for Radiofrequency Ablation in Ventricular Tachycardia (2015) (18)
Radiofrequency Ablation of Accessory Pathways: Characteristics of Transiently and Permanently Effective Pulses (1992) (18)
Temperature-controlled radiofrequency catheter ablation of manifest accessory pathways. (1996) (18)
Variability of P-wave morphology predicts the outcome of circumferential pulmonary vein isolation in patients with recurrent atrial fibrillation. (2015) (18)
Comparison of Dabigatran and Uninterrupted Warfarin in Patients With Atrial Fibrillation Undergoing Cardiac Rhythm Device Implantations. (2014) (18)
Precordial QRS amplitude ratio predicts long-term outcome after catheter ablation of electrical storm due to ventricular tachycardias in patients with arrhythmogenic right ventricular cardiomyopathy. (2015) (18)
The PROFID project (2020) (17)
Improving public health by improving clinical trial guidelines and their application (2017) (17)
Cardiac resynchronization therapy in the ageing population - With or without an implantable defibrillator? (2018) (17)
Idiopathic Outflow Tract Tachycardias (2007) (17)
Renal Denervation for Treatment of Cardiac Arrhythmias: State of the Art and Future Directions (2015) (17)
Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors. (2014) (17)
Higher burden of supraventricular ectopic complexes early after catheter ablation for atrial fibrillation is associated with increased risk of recurrent atrial fibrillation (2018) (17)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. (2020) (17)
Potential Benefits, Risks, and Complications of Catheter Ablation of Atrial Fibrillation: More Questions than Answers (2002) (17)
Impact of COVID-19 pandemic on involuntary and urgent inpatient admissions for psychiatric disorders in a German-wide hospital network (2021) (16)
A Classic Electrocardiographic Manifestation of Catecholaminergic Polymorphic Ventricular Tachycardia (2012) (16)
Effect of Limb Lead Electrodes Location on ECG and Localization of Idiopathic Outflow Tract Tachycardia: A Prospective Study (2011) (16)
Ventriculoatrial conduction and related pacemaker-mediated arrhythmias in patients implanted for atrioventricular block: an old problem revisited. (2013) (16)
Battery Malfunction of a Leadless Cardiac Pacemaker: Worrisome Single-Center Experience. (2018) (16)
Left atrial size and total atrial emptying fraction in atrial fibrillation progression. (2019) (16)
Predictors, management, and outcome of cardioversion failure early after atrial fibrillation ablation (2018) (16)
Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial (2019) (16)
3D Mapping for PVI- Geometry, Image Integration and Incorporation of Contact Force Into Work Flow. (2018) (16)
Atrioventricular nodal reentry tachycardia: Electrophysiologic comparisons in patients with and without 2:1 infra‐his block (1993) (16)
Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table (2019) (16)
A Comparative Analysis of In-Hospital Mortality per Disease Groups in Germany Before and During the COVID-19 Pandemic From 2016 to 2020 (2022) (16)
Regional and temporal disparities of excess all-cause mortality for Germany in 2020: is there more than just COVID-19? (2020) (16)
Antiarrhythmic properties of beta-blockers. (1990) (15)
Successful single-sided renal denervation in drug-resistant hypertension and ventricular tachycardia (2015) (15)
Association between ventricular arrhythmias and myocardial mechanical dispersion assessed by strain analysis in patients with nonischemic cardiomyopathy (2015) (15)
Efficacy and safety of remote magnetic catheter navigation vs. manual steerable sheath-guided ablation for catheter ablation of atrial fibrillation: a case-control study. (2015) (15)
Three-dimensional real-time MRI-guided intracardiac catheter navigation. (2014) (15)
Presence and extent of coronary artery disease as predictor for AF recurrences after catheter ablation: The Leipzig Heart Center AF Ablation Registry. (2015) (15)
Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion (2015) (15)
Variants of Preexcitation—Specialized Atriofascicular Pathways, Nodofascicular Pathways, and Fasciculoventricuiar Pathways: (1996) (15)
Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Case-control study. (2014) (15)
Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events (2019) (14)
Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis. (2012) (14)
Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience. (2019) (14)
Sensor‐Based Electromagnetic Navigation to Facilitate Implantation of Left Ventricular Leads in Cardiac Resynchronization Therapy (2015) (14)
Identification of Central Regulators of Calcium Signaling and ECM–Receptor Interaction Genetically Associated With the Progression and Recurrence of Atrial Fibrillation (2018) (14)
Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation: is it necessary? (2015) (14)
Real-life anticoagulation treatment of atrial fibrillation after catheter ablation: Possible overtreatment of low-risk patients (2009) (14)
New implantable cardiac monitor with three-lead ECG and active noise detection (2017) (14)
Preliminary experience with high-density electroanatomical mapping for ablation of atrial fibrillation - Comparison of mini-basket and novel open irrigated magnetic ablation catheter in consecutive patients. (2017) (14)
Results of catheter ablation of atrial fibrillation in hypertrophied hearts - Comparison between primary and secondary hypertrophy. (2015) (13)
Contemporary Management of Severe Symptomatic Aortic Stenosis. (2021) (13)
Diagnosis of arrhythmias in athletes using leadless, ambulatory HR monitors. (2013) (13)
Initial apixaban dosing in patients with atrial fibrillation (2018) (13)
Left ventricular diastolic dysfunction and thromboembolic risk in atrial fibrillation: diastolic dysfunction and thromboembolic risk in AF. (2013) (13)
Myeloperoxidase in atrial fibrillation: association with progression, origin and influence of renin–angiotensin system antagonists (2019) (13)
Hospitalization deficit of in‐ and outpatient cases with cardiovascular diseases and utilization of cardiological interventions during the COVID‐19 pandemic: Insights from the German‐wide helios hospital network (2021) (13)
Stable Secondary Arrhythmias Late After Intraoperative Radiofrequency Ablation of Atrial Fibrillation: (2004) (13)
Magnetic resonance imaging guided transatrial electrophysiological studies in swine using active catheter tracking – experience with 14 cases (2017) (13)
Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation (2018) (13)
Are the atrial natriuretic peptides a missing link predicting low‐voltage areas in atrial fibrillation? Introducing the novel biomarker‐based atrial fibrillation substrate prediction (ANP) score (2020) (13)
Prognostic Impact of the Timing of Recurrence of Infarct-Related Ventricular Tachycardia After Catheter Ablation (2016) (13)
Focal Impulse and Rotor Modulation Ablation vs. Pulmonary Vein isolation for the treatment of paroxysmal Atrial Fibrillation: results from the FIRMAP AF study (2020) (13)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population (2020) (13)
Utilization of in- and outpatient hospital care in Germany during the Covid-19 pandemic insights from the German-wide Helios hospital network (2021) (13)
Predictors of long-term success after catheter ablation of atriofascicular accessory pathways. (2012) (12)
Atrial Premature Beats During Decrementally Conducting Antidromic Tachycardia (2013) (12)
Subject-Specific Calculation of Left Atrial Appendage Blood-Borne Particle Residence Time Distribution in Atrial Fibrillation (2021) (12)
Global multielectrode contact‐mapping plus ablation with a single catheter in patients with atrial fibrillation: Global AF study (2019) (12)
Devices for management of sudden cardiac death: Successes, challenges and perspectives. (2017) (12)
The Role of the ICD in Patients with Dilated and Hypertrophic Cardiomyopathy (1992) (12)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (12)
Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation (2014) (12)
The effect of radiofrequency catheter ablation of frequent premature ventricular complexes and arrhythmia burden on left ventricular function. (2017) (12)
How to Evaluate Class III Antiarrhythmic Drug Efficacy Clinically: The Benefits and Shortcomings of the Invasive Approach (1992) (11)
Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies. (2015) (11)
Prediction of low-voltage areas using modified APPLE score. (2020) (11)
2016 ESC guidelines for the diagnosis and treatment of atrial fibrillation developed in collaboration with the EACTS (2017) (11)
Remote monitoring and heart failure: monitoring parameters, technology, and workflow. (2016) (11)
Patterns of left atrial activation and evaluation of atrial dyssynchrony in patients with atrial fibrillation and normal controls: Factors beyond the left atrial dimensions. (2016) (11)
Predictors of recurrence of atrial fibrillation within the first 3 months after ablation (2020) (11)
The shocking lack of evidence for implantable cardioverter defibrillators for heart failure; with or without cardiac resynchronization. (2019) (11)
Relevant ventricular septal defect caused by steam pop during ablation of premature ventricular contraction. (2013) (10)
Innovations and paradigm shifts in atrial fibrillation ablation. (2021) (10)
Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation (2018) (10)
Complex cases of acquired pulmonary vein stenosis after radiofrequency ablation: is surgical repair an option? (2019) (10)
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation (2020) (10)
Clinical Outcomes in Patients With Dilated Cardiomyopathy and Ventricular Tachycardia. (2022) (10)
Signal-Averaged Electrocardiography as a Noninvasive Tool for Evaluating the Outcomes After Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Heart Disease: Reassessment of an Old Tool (2016) (10)
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference (2022) (10)
Diagnosis of atrial tachycardias originating from the lower right atrium: importance of P-wave morphology in the precordial leads V3-V6. (2013) (10)
Trimethylamine N-oxide in atrial fibrillation progression (2020) (10)
What can rhythm control therapy contribute to prognosis in atrial fibrillation? (2015) (9)
Paraseptal Accessory Pathway in Wolff-Parkinson- White-Syndrom: Ablation from the Right, from the Left or within the Coronary Sinus/Middle Cardiac Vein? (2005) (9)
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. (2022) (9)
Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry (2019) (9)
Circulating proteomic patterns in AF related left atrial remodeling indicate involvement of coagulation and complement cascade (2018) (9)
The year in cardiology 2014: arrhythmias and device therapy. (2015) (9)
Left-septal ablation of the fast pathway in AV nodal reentrant tachycardia refractory to right septal ablation. (2005) (9)
Supraventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy associate with long-term outcome after catheter ablation of ventricular tachycardias (2018) (9)
Epicardial Adipose Tissue Thickness as an Independent Predictor of Ventricular Tachycardia Recurrence Following Ablation. (2019) (9)
Acute safety, effectiveness, and real-world clinical usage of ultra-high density mapping for ablation of cardiac arrhythmias: results of the TRUE HD study (2019) (9)
Voltage‐Based Ablation: The Growing Evidence for the Role of Individually Tailored Substrate Modification for Atrial Fibrillation (2016) (9)
Pulmonary pressure, telemedicine, and heart failure therapy (2016) (9)
Cardiac resynchronization therapy with individualized placement of two left ventricular leads at the sites of latest mechanical left ventricular contraction: guided by 3D‐echocardiography and coronary sinus rotation angiography (2010) (9)
The role of basic arrhythmia research. The continued need for experiments in the intact heart and organism. (1995) (9)
Sudden Cardiac Death in Acute Coronary Syndromes. (2017) (8)
Treating arrhythmias: an expert opinion (2011) (8)
Inguinal vascular complications after ablation of atrial fibrillation: an economic impact assessment (2018) (8)
Quantification of regurgitation in mitral valve prolapse with four-dimensional flow cardiovascular magnetic resonance (2021) (8)
An integrative approach to slow pathway modulation in AVNRT using a novel ultra high-density electroanatomical mapping system (2015) (8)
The electrocardiogram endeavour: from the Holter single-lead recordings to multilead wearable devices supported by computational machine learning algorithms. (2019) (8)
Unexpected Emergence of Manifest Preexcitation Following Transcatheter Ablation of Concealed Accessory Pathways (1993) (8)
Genomic Contributors to Rhythm Outcome of Atrial Fibrillation Catheter Ablation – Pathway Enrichment Analysis of GWAS Data (2016) (8)
Atrial fibrillation ablation: a cost or an investment? (2011) (8)
Predictors of long-term mortality after catheter ablation of ventricular tachycardia in a contemporary cohort of patients with structural heart disease. (2020) (8)
Morphological determinators of platelet activation status in patients with atrial fibrillation. (2019) (8)
A Guide to the Porcine Anatomy for the Interventional Electrophysiologist. Fluoroscopy and High Density Electroanatomical Mapping (2015) (8)
Left ventricular wall motion analysis to guide management of CRT non-responders. (2015) (8)
Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion. (1987) (8)
Catheter ablation of ventricular arrhythmias and in-hospital mortality: insights from the German-wide Helios hospital network of 5052 cases. (2019) (8)
Effects of dronedarone and amiodarone on atrial fibrillatory rate in patients with persistent atrial fibrillation. (2013) (8)
Smart Watch Devices for Atrial Fibrillation Screening: It Has to Start Somewhere. (2020) (8)
Electroanatomic Mapping of the Endocardium (2003) (8)
Requirements for 5G based telemetric cardiac monitoring (2018) (8)
Electroanatomic mapping of the endocardium. Implication for catheter ablation of ventricular tachycardia. (2003) (8)
Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology: Cardiovascular Round Table. (2022) (8)
Sex differences of resource utilisation and outcomes in patients with atrial arrhythmias and heart failure (2019) (8)
Effects of β-Blockade on the Incidence of Ventricular Tachyarrhythmias during Acute Myocardial Ischemia: Experimental Findings and Clinical Implications (1991) (8)
Remote monitoring and clinical outcomes: details on information flow and workflow in the IN-TIME study (2018) (8)
OE-106 Computed Tomography Model-based Substrate Modification of Atrium for Atrial Fibrillation Catheter Ablation(OE18,Atrial Fibrillation/Supraventricular Arrhythmia: Treatment (A),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (8)
[Short version of the 2nd edition of the German-Austrian S3 guidelines "Cardiogenic shock complicating myocardial infarction-Diagnosis, monitoring and treatment"]. (2020) (7)
Deep sedation for transvenous lead extraction: a large single-centre experience. (2019) (7)
Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (7)
[The incidence of ventricular arrhythmia following direct current ablation, high-frequency current ablation and laser photo-ablation]. (1988) (7)
Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation (2017) (7)
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2016) (7)
Atrial fibrillation monitoring: mathematics meets real life. (2012) (7)
Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey. (2020) (7)
Prevention of oesophageal injury during catheter ablation of atrial fibrillation: is monitoring of oesophageal temperature the solution? (2010) (7)
Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals (2022) (7)
Evaluation and management of ventricular tachycardia in patients with dilated cardiomyopathy. (2019) (7)
Machine learning algorithms for claims data‐based prediction of in‐hospital mortality in patients with heart failure (2021) (7)
Echinococcal cyst of the interventricular septum: a rare cause of myocardial ischemia. (1992) (7)
The European Heart Journal on the move: can scientific publishing be further improved? (2013) (7)
Natural course of acquired pulmonary vein stenosis after radiofrequency ablation for atrial fibrillation—Is routine follow‐up imaging indicated or not? (2019) (7)
Usefulness of dronedarone in patients with atrial arrhythmias. (2013) (7)
Catheter ablation of ventricular tachycardia in the setting of electrical storm after revascularization of a chronic total occlusion of the right coronary artery: An uncommon presentation of reperfusion arrhythmia (2016) (7)
Combined single-session cardiovascular magnetic resonance: stress perfusion and three-dimensional pulmonary vein angiography for stratification of atrial fibrillation patients with chest pain syndromes prior to catheter ablation. (2019) (7)
Use of diprafenone, a new potent propafenone-analogue, in acute experimental myocardial ischaemia and infarction. (1987) (7)
Impact of electroanatomical mapping-guided lead implantation on procedural outcome of His bundle pacing. (2020) (7)
Relevance of esophageal position and temperature on thermal injuries and rhythm outcome in atrial fibrillation ablations (2019) (7)
Ventricular tachycardia (1993) (7)
Electrical storm originating from a left ventricular epicardial scar in a patient with completely normal endocardial voltage (2011) (7)
Diagnostic performance of prospectively ECG triggered versus retrospectively ECG gated 64-slice computed tomography coronary angiography in a heterogeneous patient population. (2011) (7)
Quantification of Aortic Valve Regurgitation by Pulsed Doppler Examination of the Left Subclavian Artery Velocity Contour: A Validation Study with Cardiovascular Magnetic Resonance Imaging (2018) (7)
Electrophysiology testing for risk stratification of patients with ischaemic cardiomyopathy: a call for action. (2018) (7)
Comparative investigations on the antiarrhythmic and electrophysiologic effects of class I-IV antiarrhythmic agents following acute coronary artery occlusion. (1987) (7)
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology. (2021) (7)
Atrial Fibrillation detection by a subcutaneous monitoring device (2008) (7)
Clinical relevance and management of early recurrences after catheter ablation of atrial fibrillation (2011) (6)
Left Atrial Asynchrony Measured by Pulsed-Wave Tissue Doppler Is Associated With Abnormal Atrial Voltage and Recurrences of Atrial Fibrillation After Catheter Ablation. (2018) (6)
Channel‐Based Gap Mapping for Pulmonary Vein Isolation (2016) (6)
PR Interval Associated Genes, Atrial Remodeling and Rhythm Outcome of Catheter Ablation of Atrial Fibrillation—A Gene-Based Analysis of GWAS Data (2017) (6)
Rare variants in genes encoding the cardiac sodium channel and associated compounds and their impact on outcome of catheter ablation of atrial fibrillation (2017) (6)
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology (2015) (6)
Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project (2022) (6)
Antiarrhythmic medication is superior to catheter ablation in suppressing supraventricular ectopic complexes in patients with atrial fibrillation. (2017) (6)
Nd: YAG Laser‐Photocoagulation: Acute Electrophysiological, Hemodynamic, and Morphological Effects in Large Irradiated Areas (1992) (6)
Rapid ventricular pacing: a fast, reliable, and safe technique for optimization of image acquisition during rotational angiography for catheter ablation of atrial fibrillation (2011) (6)
Current Diagnostic Criteria Show a Substantial Disagreement in Classification of Patients With Suspected Cardiac Sarcoidosis. (2021) (6)
Anti-inflammatory HDL effects are impaired in atrial fibrillation (2021) (6)
Effect of atrial fibrillation ablation on left atrial contractile function in patients with paroxysmal atrial fibrillation and a relatively well preserved atrial function (2009) (6)
Exercise‐related sudden cardiac death of an American football player with arrhythmogenic right ventricular dysplasia/cardiomyopathy AND sarcoidosis (2019) (6)
Deep learning detects heart failure with preserved ejection fraction using a baseline electrocardiogram (2021) (6)
Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (6)
Extraction of infected cardiac implantable electronic devices and the need for subsequent re-implantation. (2019) (6)
Prevention of sudden cardiac death by the implantable cardioverter-defibrillator. (2018) (6)
Cardiovascular Magnetic Resonance-Guided Electrophysiological Interventions: Radiofrequency Ablation of Typical Atrial Flutter. (2017) (6)
The impact of supraventricular ectopic complexes in different age groups and risk of recurrent atrial fibrillation after antiarrhythmic medication or catheter ablation. (2018) (6)
Surgical ablation of atrial fibrillation after the PRAGUE-12 study: more questions than answers. (2012) (6)
Hospitalizations for emergency-sensitive conditions in Germany during the Covid-19 pandemic - Insights from the German-wide Helios hospital network (2021) (5)
Addition of TGF-β1 to existing clinical risk scores does not improve prediction for arrhythmia recurrences after catheter ablation of atrial fibrillation. (2016) (5)
WITHDRAWN: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation (2017) (5)
“Conventional” isthmus ablation without fluoroscopy (2013) (5)
Cardiovascular Magnetic Resonance Imaging in a Patient With Implanted Leadless Pacemaker. (2018) (5)
Differentiation of atrial fibrillation progression phenotypes using Troponin T. (2019) (5)
Antiarrhythmic therapy--future trends and forecast for the 21st century. (1997) (5)
Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial. (2022) (5)
Open source or commercial products for electronic data capture in clinical trials? a scorecard comparison (2003) (5)
Catheter Ablation of Ventricular Tachycardia in ARVC: Is Curative Treatment at the Horizon? (2006) (5)
Percutaneous transapical access for pulmonary vein mapping and ablation in a porcine model with a new high-density electroanatomical mapping system. (2015) (5)
[Non-fluoroscopic catheter tracking: the MediGuide™ system]. (2012) (5)
Non-fluoroscopic Catheter Tracking for Interventional Electrophysiology Procedures: The MediGuide System (2012) (5)
Genomic contributors to atrial electroanatomical remodeling and atrial fibrillation progression: Pathway enrichment analysis of GWAS data (2016) (5)
Accessory pathway ablation in childhood forming the substrate for ventricular tachycardia in adulthood. (2016) (5)
Feasibility and Reliability of Smartwatch to Obtain Precordial Lead Electrocardiogram Recordings (2022) (5)
P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis (2022) (5)
Significance of inducibility of atrial fibrillation after pulmonary vein isolation in patients with healthy left atrium substrate (2019) (5)
Adenosine sensitivity of retrograde fast pathway conduction in patients with slow-fast atrioventricular nodal reentrant tachycardia: a prospective study. (2014) (5)
Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation Registry. (2019) (5)
[Ion regulation disorders and cardiac arrhythmia. The relevance of sodium, potassium, calcium, and magnesium]. (1989) (5)
Epicardial ablation may not be necessary in all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and frequent ventricular tachycardia. (2017) (5)
Sunday, 26 August 2012 (2012) (5)
Ablation of atrial fibrillation (2008) (5)
Association of left ventricular late gadolinium enhancement with left atrial low voltage areas in patients with atrial fibrillation (2018) (5)
Admission Rates and Care Pathways in Patients with Atrial Fibrillation during the COVID-19 Pandemic – Insights from the German-wide Helios Hospital Network (2021) (4)
Changing coronary sinus activation during catheter ablation of isthmus-dependent right atrial flutter: what is the mechanism? (2012) (4)
EGF (Epidermal Growth Factor) Receptor Ligands in Atrial Fibrillation: From Genomic Evidence to the Identification of New Players (2019) (4)
Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic (2021) (4)
Characteristics of the ablation lesions in cardiac magnetic resonance imaging after radiofrequency ablation of ventricular arrhythmias in relation to the procedural success (2018) (4)
Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator (2020) (4)
Need for further studies on ivabradine in patients with persistent atrial fibrillation. (2016) (4)
Safety and Efficacy of Transcatheter Edge-to-Edge Repair of the Tricuspid Valve in Patients With Cardiac Implantable Electronic Device Leads. (2019) (4)
Association of low-voltage areas with the regional wall deformation and the left atrial shape in patients with atrial fibrillation: A proof of concept study (2021) (4)
Effect of remote ischemic preconditioning on electrophysiological parameters in non-valvular paroxysmal atrial fibrillation: The RIPPAF Randomized Clinical Trial. (2019) (4)
Percutaneous left atrial appendage suture ligation: not ready for prime time. (2014) (4)
First Case of Automatic His Potential Detection With a Novel Ultra High-density Electroanatomical Mapping System for AV Nodal Ablation (2016) (4)
Initial rivaroxaban dosing in patients with atrial fibrillation (2019) (4)
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). (2018) (4)
Clinical implications of pleomorphic ventricular tachycardias on oral sotalol therapy. (1995) (4)
Six-month follow-up of isthmus-dependent right atrial flutter ablation using a remote magnetic catheter navigation system: a case-control study (2010) (4)
Transvenous lead extraction in a patient with persistent left superior vena cava (2020) (4)
Shock efficacy of single and dual coil electrodes—new insights from the NORDIC ICD Trial (2018) (4)
[2020 ESC guidelines on atrial fibrillation : Summary of the most relevant recommendations and innovations]. (2020) (4)
Cardiac Mapping: Shenasa/Cardiac (2013) (4)
Positional ventricular tachycardia in left ventricular assist device: a new frontier in ventricular tachycardia ablation. (2014) (4)
Rate of acquired pulmonary vein stenosis after ablation of atrial fibrillation referred to electroanatomical mapping systems: Does it matter? (2018) (4)
Grading of aortic regurgitation by cardiovascular magnetic resonance and pulsed Doppler of the left subclavian artery: harmonizing grading scales between imaging modalities (2020) (4)
Early Mortality After Catheter Ablation of Atrial Fibrillation. (2020) (4)
Left atrial activation and asymmetric anatomical remodeling in patients with atrial fibrillation: The relation between anatomy and function (2020) (4)
Atrial fibrillation: is there a role for cardiac troponin? (2020) (4)
Clinical Implications of Recent Trials on Anticoagulation in Patients with Atrial Fibrillation (2012) (4)
Poster session 2 (2004) (4)
First clinical experience in man with the IMRICOR-MR-EP system:Electrophysiology study guided by real-time MRI (2012) (4)
Cardiac magnetic resonance imaging for coregistration during ablation of ischemic ventricular tachycardia for identification of the critical isthmus (2017) (4)
Catheter ablation of atrial fibrillation with nonfluoroscopic catheter visualization—a prospective randomized comparison (2018) (4)
Current status and future catheter ablation strategies in atrial fibrillation (2014) (4)
National mortality data for Germany before and throughout the pandemic: There is an excess mortality exceeding COVID-19-attributed fatalities (2022) (3)
Incidence and characteristics of ventricular tachycardia in patients after percutaneous coronary revascularization of chronic total occlusions (2019) (3)
Successful integration of a computed tomography-based left atrial three-dimensional model in an electroanatomically reconstructed right atrium for ablation of biatrial tachycardia. (2011) (3)
Abnormal pattern of left atrial activation and asynchronous conduction predicted the occurrence of new atrial fibrillation: evidences for Bachmann's bundle block in atrial fibrillation pathophysiology. (2021) (3)
Transvenous revision of leads with cardiac perforation following device implantation—Safety, outcome, and complications (2020) (3)
Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II (2019) (3)
NT-proBNP in "low risk" patients with atrial fibrillation. (2015) (3)
Beyond Pulmonary Vein Isolation: The Issue of Reconduction (2009) (3)
New familial heterozygous c 4066_4068 delTT 2 bp deletion of the SCN5A gene causing Brugada syndrome. (2011) (3)
Cardiovascular magnetic resonance imaging for the detection and follow-up of isolated partial anomalous pulmonary venous connection. (2015) (3)
Cardiovascular magnetic resonance imaging for the detection of left atrial remodeling and the prediction of atrial fibrillation ablation success: More than meets the eye. (2020) (3)
Prevention of thromboembolism after cardioversion of recent-onset atrial fibrillation: brief is not always safe. (2013) (3)
Right ventricular pacing for control of right atrial isthmus block: a new colorful piece in the mosaic. (2006) (3)
Outcome of super-responders to cardiac resynchronization therapy defined by endpoint-derived parameters of left ventricular remodeling: a two-center retrospective study (2015) (3)
Effect of remote ischemic preconditioning on electrophysiological and biomolecular parameters in nonvalvular paroxysmal atrial fibrillation (RIPPAF study): Rationale and study design of a randomized, controlled clinical trial (2016) (3)
Two concomitant arrhythmias in a transplanted heart (2009) (3)
Effect of Exercise on Outcome after Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (2019) (3)
SAFER. (2018) (3)
Cardiac resynchronization therapy: haemodynamic background and perspectives (2007) (3)
Electroanatomical high-density mapping of different tachycardias in the right atrium after heart transplantation (2016) (3)
Effects of baseline P-wave duration and choice of atrial septal pacing site on shortening atrial activation time during pacing. (2012) (3)
Myocardial voltage ratio in arrhythmogenic right ventricular dysplasia/cardiomyopathy (2017) (3)
Hospitalisations for emergency-sensitive conditions in Germany during the COVID-19 pandemic: insights from the German-wide Helios hospital network (2021) (3)
Innovation in cardiovascular disease in Europe with focus on arrhythmias: current status, opportunities, roadblocks, and the role of multiple stakeholders. (2018) (3)
Moving catheter ablation forward from paroxysmal to persistent atrial fibrillation: progress, limitations, and surprises of the SARA trial (2013) (3)
The Year in Cardiology 2016: arrhythmias and cardiac implantable electronic devices. (2017) (3)
Digital health solutions in the screening of subclinical atrial fibrillation (2021) (3)
Monday, 27 August 2012 (2012) (3)
MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial (2022) (3)
Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study (2022) (3)
Left ventricular lead implantation guided by sensor-based electromagnetic navigation in a patient with L-transposition of the great arteries. (2014) (3)
The Year in Cardiology 2015: Arrhythmias and Device Therapy (2016) (3)
Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms (2020) (3)
[Initial presentation of ventricular pre-excitation after catheter ablation of concealed retrograde conducting accessory atrioventricular pathways]. (1992) (2)
Management of patients with heart failure and secondary mitral regurgitation (2020) (2)
Low right atrial tachycardia with positive P waves in the inferior leads: Explanation by electroanatomical mapping (2006) (2)
VERNAKALANT FACILITATED ELECTRICAL CARDIOVERSION: A RANDOMIZED, OPEN LABEL PILOT STUDY COMPARING INTRAVENOUS VERNAKALANT AND AMIODARONE FOR DRUG-ENHANCED ELECTRICAL CARDIOVERSION OF CARDIOVERSION-RESISTANT ATRIAL FIBRILLATION (2013) (2)
Changes in left atrial function in patients undergoing cardioversion for atrial fibrillation: relevance of left atrial strain in heart failure (2021) (2)
Iatrogenic atrial septal defect after catheter ablation of atrial fibrillation: do we have to worry? (2010) (2)
DABIGATRAN IN PATIENTS POST ATRIAL FIBRILLATION ABLATION (2012) (2)
Novel Pacemaker-Mediated Arrhythmia Without Ventriculoatrial Conduction Can Induce Atrial Fibrillation. (2021) (2)
[Constellations of findings and derived treatment interventions in telemedical monitoring of patients with heart failure, cardiac arrhythmia or increased risk for sudden cardiac death : Recommendations of the working group 33 telemonitoring of the German Cardiac Society]. (2019) (2)
Cardiac resynchronization therapy in heart failure: is the defibrillator needed? (2018) (2)
Respiratory cycle-dependent left atrial tachycardia in a former Tour de France cyclist. (2015) (2)
The Year in Cardiology 2013: arrhythmias. (2014) (2)
Non-compaction cardiomyopathy and incessant supraventricular tachycardia: an unusual first presentation. (2017) (2)
Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease. (2016) (2)
Sharing cardiology cases with students and doctors over the WWW: the Kasus-platform at the Heart Center Leipzig (2000) (2)
Sinus node modification with an ultra high-density electroanatomical mapping system in inappropriate sinus tachycardia. (2017) (2)
Results of Recent Studies in Catheter Ablation of Ventricular Tachycardias (2009) (2)
A Latent Atrioventricular Decrementally Conducting Accessory Pathway Mimicking a Bystander Nodoventricular Fiber (2010) (2)
Controversies in cardiovascular medicine Risk stratification after myocardial infarction : is left ventricular ejection fraction enough to prevent sudden cardiac death ? (2013) (2)
[The pro-arrhythmic effects of anti-arrhythmia agents]. (1994) (2)
Does catheter ablation eliminate the need for oral anticoagulation? (2011) (2)
Flecainide-Associated Cardiogenic Shock in a Patient with Atrial Fibrillation (2019) (2)
Letter regarding article, "Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities". (2012) (2)
Outcome in patients undergoing upgrade to cardiac resynchronization therapy: predictors of outcome after upgrade to CRT (2019) (2)
Educational needs among physicians treating patients with atrial fibrillation: lessons for Poland from the European Society of Cardiology international educational needs assessment study. (2019) (2)
Gender differences in patients with structural heart disease undergoing VT ablation (2021) (2)
Electroanatomical mapping–guided left bundle branch area pacing in patients with structural heart disease and advanced conduction abnormalities (2022) (2)
Abstract 2859: Catheter Contact Force During Ablation of Atrial Flutter and Atrial Fibrillation: Results From the TOCCATA Multi-Center Clinical Study (2009) (2)
[Biomarkers and atrial fibrillation : Prediction of recurrences and thromboembolic events after rhythm control management]. (2018) (2)
Questionable levels of evidence in new atrial fibrillation guidelines (2013) (2)
Ablation of typical atrial flutter using a novel non-fluoroscopic electromagnetic catheter tracking system (2014) (2)
New Strategies to Improve Rhythm Outcome of Catheter Ablation of Persistent and Longstanding Persistent Atrial Fibrillation: Hunting Rotors and Focal Sources. (2016) (2)
Investigating relationships between left atrial volume, symmetry, and sphericity (2016) (2)
Old Habits Die Hard: The Quest for Correct(ed) QT Interval Measurements (2010) (2)
[Three-dimensional mapping : Special aspects and new features of CARTO®]. (2018) (2)
Atrial remodeling and atrial fibrillation recurrence after catheter ablation (2021) (2)
[Percutaneous endocardial Nd-YAG laser energy: experimental studies of ablation of the ventricular myocardium]. (1991) (2)
Tumor Or Thrombus? The Role Of Cardiac Magnetic Resonance Imaging In Differentiating Left Atrial Mass In a Transplanted Heart: A Case Report. (2017) (2)
Expect the unexpected: lead fracture in a subcutaneous defibrillator. (2020) (2)
Effects of beta-blockade on the incidence of ventricular tachyarrhythmias during acute myocardial ischemia: experimental findings and clinical implications. (1990) (2)
Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation. (2016) (2)
Catheter Ablation of Idiopathic Left Ventricular Tachycardia: Use of New Mapping Technologies– When and Why (2000) (2)
Atrial septum biopsy for direct substrate characterization in atrial fibrillation (2019) (2)
Sleep Disorders and Atrial Fibrillation: Current Situation and Future Directions (2018) (2)
Agreement between gadolinium-enhanced cardiac magnetic resonance and electro-anatomical maps in patients with non-ischaemic dilated cardiomyopathy and ventricular arrhythmias. (2019) (2)
Catheter ablation of atrial flutter: Critical isthmus identification and localization. (2020) (2)
Daily remote monitoring of implantable cardioverter-defibrillators (2017) (2)
Idiopathic Premature Ventricular Contraction Conducting over a Ventricle Myocardial Extension from the Pulmonary Artery (2016) (2)
The Role of Renal Sympathetic Denervation in Atrial Fibrillation. (2014) (2)
Digital health: Present conundrum, future hope or hype? (2019) (2)
Quantification of regurgitation in mitral valve prolapse with automated real time echocardiographic 3D proximal isovelocity surface area: multimodality consistency and role of eccentricity index (2021) (2)
Torsade de Pointes in a Patient With Wolff-Parkinson-White Syndrome (2005) (1)
Images in cardiovascular medicine. Torsade de pointes in a patient with Wolff-Parkinson-White syndrome. (2005) (1)
Catheter ablation of atrial fibrillation: recent advances and future challenges (2022) (1)
High electrical activity at the connection site of previously undetected anomalous pulmonary venous drainage in a patient presenting with atrial fibrillation (2017) (1)
Device runtime and costs of cardiac resynchronization therapy pacemakers – a health claims data analysis (2022) (1)
J wave pattern in unexplained syncope. (2015) (1)
"Pseudo" Hisian extrasystole arising from the proximal portion of the left bundle branch. (2018) (1)
Exercise and Atrial Fibrillation: Some Good News and Some Bad News (2018) (1)
Correction: Effect of Exercise on Outcome after Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (2019) (1)
A real-time monitoring tool for multicentre studies in cardiology (2000) (1)
New Technologies for Catheter Ablation of Atrial Fibrillation (2011) (1)
Role of inducibility and its dynamic change in the outcome of catheter ablation of atrial fibrillation: a single center prospective study (2020) (1)
Antiarrhythmic Properties of β‐Blockers (1990) (1)
‘Patient choice’ concept in AF ESC Guidelines: is the clinician giving up? Reply (2013) (1)
Antiarrhythmic Drug Action: Modulation by Disease and Injury (1995) (1)
Electrical and Anatomical Mapping of Different Pathologies: Ischemic, Dilated, and Hypertrophic Cardiomyopathies (2009) (1)
Remote ischemic preconditioning in a setting of electrical cardioversion of early onset persistent atrial fibrillation (RIP CAF trial): Rationale and study design. (2020) (1)
Clinical Implications from Recent Trials and New Guidelines for Stroke Prevention in Atrial Fibrillation (2012) (1)
Remote monitoring, healthcare costs, and workload for healthcare professionals. (2019) (1)
Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial (2023) (1)
Universitet Integrating new approaches to atrial fibrillation management the 6 th AFNET / EHRA Consensus Conference (2018) (1)
In vivo validation of a novel algorithm for automatic premature ventricular contractions recognition (2017) (1)
Erratum to “Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency” [Eur J Heart Fail 2016;18:482‐489] (2016) (1)
Does the origin of ablated premature ventricular contractions determine the level of left ventricular function improvement? (2020) (1)
Delineation of anatomical relation of important adjacent structures to the left atrium in electroanatomical mapping using fluoroscopy images. (2008) (1)
Rhythm outcome after circular plus linear left atrial lesions for treatment of atrial fibrillation by the means of serial continuous 7-day-ECGs (2005) (1)
Right ventricular tachycardia-arrhythmogenic right ventricular cardiomyopathy or idiopathic? (2003) (1)
Dynamic changes in the signal-averaged electrocardiogram are associated with the long-term outcomes after ablation of ischemic ventricular tachycardia (2020) (1)
Patients’ preferences regarding the digital capturing of patient-reported outcomes: planning the future follow-up in a prospective heart failure registry (2021) (1)
[Psychiatric Emergency Admissions and Inpatient Length of Stay Before and During the COVID-19 Pandemic in Germany]. (2022) (1)
Value of Cardiogoniometry in Diagnosis of Coronary Artery Disease in Patients with Suspected Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis. (2019) (1)
LV Pseudoaneurysm With Concomitant Mitral Valve Defect After LV Summit Ablation (2021) (1)
3-D-Mapping (2018) (1)
Magnesium — Electrophysiological Effects, Antiarrhythmic Properties and Clinical Applications (1995) (1)
Cardiovascular magnetic resonance-based predictors of complete left ventricular systolic functional recovery after rhythm restoration in patients with atrial tachyarrhythmia. (2021) (1)
Real-Time MRI Mapping and Ablation (2019) (1)
Response to the letter "Worsened diastology after radiofrequency catheter ablation in AF patients: more touches more stiff left atrium". (2013) (1)
Abstract 2197: A Genotype Dependent Intermediate ECG Phenotype in Patients with Persistent Lone Atrial Fibrillation (2007) (1)
Patients’ attitude towards a sham-controlled trial on pulmonary vein isolation in atrial fibrillation (2021) (1)
Hospital Equipment and Facilities, Personnel, Training Requirements, and Competences (2011) (1)
Optimal timing of contrast-enhanced three-dimensional magnetic resonance left atrial angiography before pulmonary vein ablation. (2013) (1)
Characterizing left ventricular mechanical and electrical activation in patients with normal and impaired systolic function using a non-fluoroscopic cardiovascular navigation system (2018) (1)
[Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference]. (2007) (1)
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe. (2023) (1)
[Management of syncope in clinical practice : What has changed according to the new ESC guidelines 2018?] (2018) (1)
A Prima Vista Ablation of Ventricular Tachycardia: Should We Abandon the Mapping of VT? (2016) (1)
Comparing paper-based vs. Internet-/handheld-based clinical trial coordination in a study on Hernia inguinalis: how good is cost/benefit ratio? (2000) (1)
[Percutaneous high frequency current catheter ablation in permanent ventricular tachycardia of the "bundle-branch reentry" type after implantation of an automatic cardioverter-defibrillator]. (1992) (1)
Epicardial ablation of ventricular tachycardia in patients with structural heart disease: a single-centre experience over 12 years. (2021) (1)
Impact of single versus double transseptal puncture on outcome and complications in pulmonary vein isolation procedures. (2020) (1)
Stepwise Approach to Management of Atrial Arrhythmias after Catheter Ablation of Atrial Fibrillation (2012) (1)
Ethical issues in two parallel trials of personalised criteria for implantation of implantable cardioverter defibrillators for primary prevention: the PROFID project—a position paper (2021) (1)
P787Clinical recognition of pure premature ventricular complex-induced cardiomyopathy at presentation (2017) (1)
INCIDENCE, CHARACTERISTIC AND RISK FACTORS OF CEREBRAL THROMBOEMBOLIC COMPLICATIONS FOLLOWING HIGH-FREQUENCY CATHETER ABLATION OF ATRIAL FIBRILLATION: EXPERIENCE OF 3,360 PROCEDURES (2013) (1)
Impact of Catheter Ablation on Quality of Life in Patients with Atrial Fibrillation (2012) (1)
Safety and feasibility of transcatheter renal sympathetic denervation using different types of catheter and various radiofrequency settings (2016) (1)
Significance of early recurrences after circular and linear left atrial ablation for treatment of atrial fibrillation (2005) (1)
Cardiac magnetic resonance imaging reveals extensive biventricular fibrosis and inflammation challenging the diagnosis of ARVC (2015) (1)
B-PO01-047 PULSED FIELD ABLATION AND HEAT GENERATION: ELECTRODE-TISSUE TEMPERATURE ANALYSIS FROM THE PULSED AF TRIAL (2021) (1)
Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis. (2018) (1)
Long-Term Outcome of Catheter Ablation of Electrical Storm due to Recurrent Ventricular Tachycardia in a Large Cohort of Patients with Idiopathic Dilated Cardiomyopathy (2013) (1)
Potential Contributors to Increased Pulmonary Embolism Hospitalizations During the COVID-19 Pandemic: Insights From the German-Wide Helios Hospital Network (2021) (1)
Principles of NavX Mapping (2009) (1)
ICD Implantation in Patients with Nonischemic Heart Failure. (2017) (1)
Catheter ablation for atrial fibrillation: impact on mortality, morbidity, quality of life, and implications for the future (2022) (1)
Big Data in electrophysiology (2022) (1)
Mapping-guided characterization of mechanical and electrical activation patterns in patients with normal systolic function using a sensor-based tracking technology (2016) (1)
Pain During "Noncomplex" Electrophysiological Studies and Cardiac Rhythm Device Surgery. (2019) (1)
[Current state of treatment strategies for atrial fibrillation]. (2016) (1)
Atrial Fibrillation in Heart Failure—Diagnostic, Therapeutic, and Prognostic Relevance (2019) (1)
Telemonitoring von implantierten kardialen Devices (2018) (1)
VT ablation in geriatric patients with structural heart disease: Should there still be an age limit? (2021) (1)
Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation (2021) (1)
Abstract 16688: Calculating the Probability of Presence of Left Atrial Arrhythmogenic Substrate: Dr-Flash Score (2013) (1)
NT-proANP levels in peripheral and cardiac circulation (2021) (1)
Cardiopulmonary effects of constant-flow ventilation in experimental myocardial ischaemia. (1991) (1)
International Consensus Document on Atrial Fibrillation Ablation (2007) (1)
Fibrillation: Results From a Worldwide Survey in 34 943 Atrial Fibrillation Ablation Effects of Sex on the Incidence of Cardiac Tamponade After Catheter Ablation of Atrial (2014) (1)
Quantitative trigger analysis more than three years after left atrial substrate modification for treatment of atrial fibrillation (2005) (1)
Impact of Metabolic Syndrome on Left Atrial Electro-Anatomical Remodeling and Outcomes after Radiofrequency Ablation of Non-Valvular Atrial Fibrillation (2014) (1)
Letter from Kosiuk et al Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial". (2016) (1)
Emergency Covered Stent Implantation For Rupture Of A Pulmonary Vein After Balloon Angioplasty For Postinterventional Pulmonary Vein Stenosis. (2016) (1)
Female gender and atrial fibrillation: An association with worse prognosis and outcomes. (2015) (1)
Dispersion of Ventricular Refractoriness in Experimental Myocardial Infarction: Effect of Sotalol (1994) (1)
Calcium antagonists and acute myocardial ischemia: Comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds (1987) (1)
Hospital care of patients with inherited cardiomyopathies in Germany during the Covid‐19 pandemic insights from the German‐wide Helios hospital network (2021) (1)
Abstract 18321: Impact of Single Catheter Ablation of Atrial Fibrillation on Appropriate and Inappropriate Implantable Cardioverter Defibrillator Therapies in Patients with Cardiomyopathy (2012) (1)
Feasibility of NDYAG Laser Photo-Coagulation using a Sapphire Contact Probe (2009) (1)
Atrial fibrillation ablation in heart failure: it's not all about Starling my darling. (2019) (1)
Rhythm Outcomes and Quantitative Analysis of Isolation Area after Circumferential Pulmonary Vein Antrum Isolation in Patients with Paroxysmal Atrial Fibrillation (2011) (0)
Synkopenmanagement in der Praxis (2018) (0)
Cardiac Contractility Modulation (CCM) Is Equally Effective in Patients with Normal or Prolonged QRS Duration: Results of a Responder's Analysis (2007) (0)
From population- to patient-based prediction of in-hospital mortality in heart failure using machine learning (2022) (0)
Attitude towards gaining medical information in mideuropean population - first results (2000) (0)
Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial. (2022) (0)
Catheter ablation of atrial flutter: Critical isthmus identification and localization (2020) (0)
Pathophysiological Gaps, Diagnostic Challenges, and Uncertainties in Cardiac Sarcoidosis. (2023) (0)
Anything that can be measured can be improved: the case of performance measures in heart failure and beyond. (2018) (0)
Long-term adherence to dronedarone in patients with atrial arrhythmias. (2016) (0)
Differenzialdiagnostik unklarer Synkopen (2019) (0)
Abstract 16829: Isolated Left Atrial, Biatrial or Right Atrial Dilatation - Association With Low Voltage Areas in Patients With Atrial Fibrillation (2020) (0)
Wednesday, 29 August 2012 (2012) (0)
Epicardial versus tranvenous approach for left ventricular lead placement in patients receiving CRT – a randomized prospective study (2007) (0)
Impact of single atrialfibrillation catheter ablation onimplantablecardioverterdefibrillatortherapies in patients with ischaemic and non-ischaemic (2014) (0)
Reply: Elimination of All Inducible Ventricular Tachycardias as the Endpoint for Ablation. (2015) (0)
Percutaneous Left Atrial Appendage Suture Ligation (2014) (0)
17-01: Challenges in selecting rate vs. rhythm control in Atrial Fibrillation (2016) (0)
To the Editor- Thoughts on inducibility. (2019) (0)
MUTATIONS IN GENES ENCODING THE CARDIAC SODIUM CHANNEL AND ASSOCIATED COMPOUNDS AND THEIR IMPACT ON OUTCOME OF CATHETER ABLATION FOR ATRIAL FIBRILLATION (2013) (0)
Abstract 3522: Selection of the Latest LV Contration Site for LV Lead Placement Based on Integration of 3D TEE and CS Rotation Angiography Information (2009) (0)
[Differential diagnostics of unclear syncope]. (2019) (0)
[Ablation of incessant ventricular tachycardia with the use of epicardial approach in a patient after CABG - a case report]. (2011) (0)
Renal denervation in challenging anatomy: Current strategies and pre-procedural imaging. (2016) (0)
Gerhard Hindricks MD Gerhard Hindricks , New President of the European Heart Rhythm Association ( EHRA ) , shares his aims and ambitions for the group (2016) (0)
Abstract 13369: Comparison of Outcome after Ventricular Tachycardia Ablation in Ischaemic and Non-Ischaemic Cardiomyopathy (2012) (0)
Predictors of appropriate and inappropriate Therapies in Patients with implantable cardioverter-defibrillator and Structural Heart Disease (2016) (0)
VT Ablation for Recurrent Ventricular Tachycardia after Implantation of a Left Ventricular Assist Device (2015) (0)
Risk stratification for sudden cardiac death in ischaemic cardiomyopathy (2018) (0)
[Telemonitoring of implanted cardiac devices : Clinical necessity or senseless luxury?] (2018) (0)
Conference Programme (2020) (0)
Dysinnervation in Arrhythmogenic Right Ventricular Cardiomyopathy (2005) (0)
Effect of sotalol on RR interval variability during induced ventricular tachycardia. (1996) (0)
The Year in Cardiology The Year in Cardiology 2013 : arrhythmias (2014) (0)
Role of assist device implantation and heart transplantation in the long-term outcome of patients with structural heart disease after catheter ablation of ventricular tachycardia (2021) (0)
CARDIAC MAGNETIC RESONANCE IMAGING AFTER RADIOFREQUENCY ABLATION OF VENTRICULAR ARRHYTHMIAS IN HUMAN PATIENTS: DEFINING THE SUBSTRATE AND VISUALIZING THE OUTCOME (2017) (0)
Hospitalization Rates and In-Hospital Mortality Before and During the COVID-19 Pandemic. (2022) (0)
The implantable cardioverter defibrillator. Conclusions on sudden cardiac death and future perspective (2018) (0)
69-01: The role of cardiac magnetic resonance imaging in patients undergoing ablation for ventricular tachycardia: Defining the substrate and visualizing the outcome (2016) (0)
Close the gap to get a circle! The role of visual gaps during circumferential pulmonary vein isolation. (2012) (0)
The role of angiotensin in electrophysiological gap junction remodeling in human atrial fibrillation (2004) (0)
The Future of Cardiac Mapping: Dawn of a New Decade (2012) (0)
Erratum to: Big Data in electrophysiology (2022) (0)
Abstract 5925: Temporary Percutaneus Left Ventricular Stimulation in Patients with Cardiogenic Shock and Asynchronous Left Ventricular Contraction (2008) (0)
Emerging Cardiac Resynchronisation Therapy Indications (2010) (0)
CardioPulse:Leipzig Heart Centre – Department of Electrophysiology. (2016) (0)
Role of Drugs in Torsade de Pointes and Triggered Activity (1995) (0)
EHJ's new impact factor of 15.2: a global strategy is paying off. (2015) (0)
The A Wave Method—An alternative Approach for Determining the Atrial Pacing Threshold (2011) (0)
Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole. (2023) (0)
Abstract 13807: Impact of Metabolic Syndrome on Left Atrial Remodelling and Outcomes After Radiofrequency Ablation for Atrial Fibrillation (2013) (0)
Effect of contact force on pulsed field ablation lesions in porcine cardiac tissue (2023) (0)
[Current applications of hypnosis in the field of cardiac electrophysiology]. (2021) (0)
Concomitant bilateral video-assisted thoracoscopic sympathectomy and minimal-invasive left ventricular assist device implantation. (2021) (0)
P-WAVE DURATION AND ATRIAL FIBRILLATION RECURRENCE AFTER CATHETER ABLATION. AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (0)
A single-center experience in transvenous coronary sinus lead extraction and re-implantation. Technical issues and alternative re-implantation approaches (2013) (0)
B-PO03-121 CONTACT FORCE BY DEFORMATION OF ABLATION CATHETERS: CAN WE PREDICT BY BENDING? (2021) (0)
Does the origin of ablated premature ventricular contractions determine the level of left ventricle remodeling? (2020) (0)
B-IN02-08 PULSED FIELD ABLATION AND HEAT GENERATION: ELECTRODE-TISSUE TEMPERATURE ANALYSIS FROM THE PULSED AF TRIAL (2021) (0)
PE-002 Role of Intraesophageal Temperature Monitoring to Prevent Esophageal Injury during Atrial Fibrillation Catheter Ablation(PE001,Atrial/Supraventricular Arrhythmia (Clinical/Treatment) 1 (A),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
Cardiac Resynchronization Therapy in Heart Failure (2021) (0)
Abstract 13207: Successful Catheter Ablation of Symptomatic Ventricular Arrhythmia After Left Ventricular Assist Device Implantation (2016) (0)
Correction to: Dynamic changes in the signal-averaged electrocardiogram are associated with the long-term outcomes after ablation of ischemic ventricular tachycardia (2021) (0)
Gerhard Hindricks and Christopher Piorkowski Atrial Fibrillation Monitoring : Mathematics Meets Real Life (2012) (0)
Mapping and Ablation of Left Atrial Flutter and Tachycardia (2019) (0)
RISK ASSESSMENT OF RECURRENT ATRIAL FIBRILLATION AFTER ANTIARRHYTHMIC MEDICATION OR CATHETER ABLATION: THE IMPACT OF AGE AND SUPRAVENTRICULAR ECTOPIC COMPLEXES (2017) (0)
[Telemedicine and ECG monitoring : Technical prerequisites and clinical workflow]. (2020) (0)
MED23/404: The KASUS-Platform for Problem-Oriented Learning Groups: Using a digital camera and a Palm Pilot II to document clinical cases and share them over the WWW (1999) (0)
Mechanistic assessment and ablation of left ventricular assist device related ventricular tachycardia in patients with severe heart failure (2023) (0)
Identification of the Patient at High Risk for Sudden Cardiac Death: The Value of Ventricular Late Potentials (1992) (0)
176-81: Implanted defibrillators in trouble: initial device misclassification leads to correct diagnosis (2016) (0)
Abstract 13857: Catheter Ablation of Atrial Fibrillation Using a New Non-Fluoroscopic Sensor-Guided 3D Navigation Tool (2011) (0)
Improvement of heart failure by electrical modulation of cardiac contractility (2003) (0)
Advanced Imaging Integration for Catheter Ablation of Ventricular Tachycardia. (2023) (0)
A long-term cost-effectiveness analysis of cardiac resynchronisation therapy with or without defibrillator based on health claims data (2022) (0)
Electrophysiologic, haemodynamic and antiarrhythmic effects of the new class Ic agent 1-(2'-biphenyloxy)-2-tert.-butylamino-propanol-2-hydrochloride. (1989) (0)
Cardiovascular magnetic resonance pulmonary perfusion for guidance of interventional treatment of pulmonary vein stenosis (2022) (0)
209-02: European-Focal Impulse and Rotor Modulation Registry –First Results of the E-FIRM Registry (2016) (0)
Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation (2018) (0)
Atrial fibrillation: the era of scientific breakthrough. (2018) (0)
Recurrent Ventricular Tachycardia After Implantation of a Left Ventricular Assist Device: Is an Endocardial Ablation an Option? (2015) (0)
How to supplement endpoints of ventricular tachycardia ablation: is there a role for noninvasive programmed ventricular stimulation? (2012) (0)
Association of atrial fibrillation susceptibility genes, atrial fibrillation phenotypes and response to catheter ablation: a gene-based analysis of GWAS data (2017) (0)
Correction to: Arginine derivatives in atrial fibrillation progression phenotypes (2021) (0)
Catheter Ablation for Recurrent Ventricular Tachycardia After Implantation of a Left Ventricular Assist Device: A Interdisciplinary Approach (2016) (0)
73-03: Supraventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy (2016) (0)
Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry (2019) (0)
Heart Teams in atrial fibrillation (2018) (0)
Abstract 16821: Common Atrial Fibrillation Susceptibility Alleles - Predictors for Atrial Fibrillation Recurrence after Catheter Ablation? (2012) (0)
Re-thinking AF progression, or how to deal with electro-anatomical substrate in paroxysmal AF. (2019) (0)
Statistical genetics with application to population-based study design : a primer for clinicians (2014) (0)
Quality criteria for performing catheter ablation of atrial fibrillation . Position paper of the German Cardiac Society (2017) (0)
Gerhard Hindricks and Hans Kottkamp Simultaneous Noncontact Mapping of Left Atrium in Patients With Paroxysmal Atrial Fibrillation (2001) (0)
Editorial: EP Europace - Present and Future. (2018) (0)
Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience Pacing and cardiac resynchronization therapy (2019) (0)
A novel ECG finding in patients with epicardial infarct-associated ventricular tachycardia: a case series (2022) (0)
Temperature‐controlled Radiofrequency Catheter Ablation of Accessory Pathways and Atrioventricular Nodal Reentrant Tachycardia: The 5‐French Catheter Approach (1996) (0)
Remote Monitoring Reduces Mortality in ICD and CRT-D Patients (2014) (0)
Effects of gallopamil and nifedipine on ventricular arrhythmias, ventricular fibrillation, epicardial conduction delays and changes in the ventricular fibrillation threshold with time during myocardial ischaemia and reperfusion (1989) (0)
Establishing a pain management program in cardiology: what we can learn from social marketing and normalization process theory Implementation of pain management in cardiology (2020) (0)
Cardiovascular surgeryAbstractTrigger Activity More Than Three Years After Left Atrial Linear Ablation Without Pulmonary Vein Isolation in Patients With Atrial Fibrillation (2005) (0)
Implication for Catheter Ablation of Ventricular Tachycardia (0)
P1443Left atrial tachycardia due to accessory pulmonary roof-vein - Case report (2017) (0)
Heart failure / cardiomyopathy Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy (2014) (0)
Economical and Technical/Medicojuristical Aspects of Different Remote-Data-Entry Scenarios: A Project Study (2001) (0)
MRI-guided Electrophysiological Interventions in Swine using Active Tracking and passive Catheter Visualization (2014) (0)
Changing trends of patient characteristics and treatment pathways during the COVID-19 pandemic: A cross-sectional analysis of 72,459 inpatient cases from the German Helios database (2022) (0)
Safety and feasibility of same-day discharge following catheter ablation of atrial fibrillation: what is known and what needs to be explored? (2022) (0)
Implanted defibrillators in trouble: initial device misclassification leads to correct diagnosis—a case series (2016) (0)
[Long-term results of catheter ablation of atrial fibrillation: cure or just palliation?]. (2014) (0)
Correspondence on “Possible spontaneous PFO closure after thrombus trapped in PFO”, Antonia Schulz et al., Clin Res Cardiol 2014; 103:333-335 (2014) (0)
Abstract 20107: Randomized Comparison of Personalized versus Standardized Substrate Modification During Catheter Ablation for Symptomatic Atrial Fibrillation (2015) (0)
Management of patients with electrical storm: an educational review. (2022) (0)
Comments on the 2015 ESC guidelines on ventricular arrhythmia and prevention of sudden cardiac death (2017) (0)
第21回日本心電学会学術集会:モーニングセミナー―抄録― (2004) (0)
OCEAN Trial Update. (2021) (0)
Hemodynamic and electrophysiologic effects of milrinone in the ischemic failing heart (1989) (0)
Follow‐up after ablation: assessing success, symptom status, and recurrent arrhythmias (2015) (0)
Device Therapy for Heart Failure: New Approaches Under Investigation (2015) (0)
From MAZE to ICE: new concepts and new technologies for surgical ablation of atrial fibrillation. (2007) (0)
Time to Connect with Europe's Strongest Heart Rhythm Network. (2016) (0)
Imaging Tools, Energy Sources and Catheters for Ventricular Tachycardia/Ventricular Fibrillation Ablation (2009) (0)
Abstract 2548: Intraesophageal Temperature Monitoring During Radiofrequency Catheter Ablation of Atrial Fibrillation: Does it Predict Esophageal Injury? (2009) (0)
[A new 2-channel stimulation instrument with integrated ablation control for diagnosis and therapy of cardiac arrhythmias]. (1988) (0)
P310HDL-function in atrial fibrillation (2018) (0)
Implantable Monitors - Recent Developments (2010) (0)
Současné a budoucí strategie katetrizační ablace fi brilace síní ( Current status and future catheter ablation strategies in atrial fi brillation ) (2014) (0)
Successful Ablation of Single Reentrant Ventricular Tachycardia Arising from Peri-Aortic Scar in a Patient with an Apparently Normal Heart. (2015) (0)
96-67: Left Ventricular Motion and Strain Profiles in Patients with Normal and Impaired Systolic Function: Evaluating a Sensor-Based, Non-Fluoroscopic Tracking Technology (2016) (0)
Relevance of Chronic Total Occlusion for Outcome of Ventricular Tachycardia Ablation in Ischemic Cardiomyopathy (2022) (0)
Differenzialdiagnostik unklarer Synkopen (2020) (0)
Collecting and calculating medical data via the internet - workshop remote data entry (RDE): designing and implementing solutions for your medical business (2000) (0)
P-wave duration and interatrial block as predictors of new-onset atrial fibrillation: A systematic review and meta-analysis. (2023) (0)
Ventricular arrhythmias and sudden cardiac death: new research insights with clinical implications (2018) (0)
A Digital Infrastructure for Cardiovascular Patient Care Based on Mobile Health Data and Patient-Reported Outcomes: Concept Details of the Helios TeleWear Project Including Preliminary Experiences (2022) (0)
Arginine derivatives in atrial fibrillation progression phenotypes (2020) (0)
Abstract 13979: Left Atrial Symmetry Changes in Atrial Fibrillation: Relation With Diastolic Dysfunction and Symptom Severity (2014) (0)
Moderating rhythmologic topics over the internet: a first years experience at the heart center Leipzig (2000) (0)
A Future Perspective on the Europace Journal: its Star is Rising. (2017) (0)
[Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct]. (1988) (0)
ISOLATED CARDIAC SARCOIDOSIS MIMICKING HYPERTROPHIC CARDIOMYOPATHY (2017) (0)
Effect of concomitant Renal DeNervation and cardiac ablation on Atrial Fibrillation recurrence – RDN+AF study (2022) (0)
Abstract 15885: Disagreement of the Current Diagnostic Criteria for Cardiac Sarcoidosis (2020) (0)
Comparison of the CARTO map and the true left atrial anatomy on multislice CT (2005) (0)
Silent active device tracking for MR‐guided interventional procedures (2022) (0)
Mapping of Macroreentrant Atrial Tachycardias (2009) (0)
Letter by Kosiuk et al regarding article, "implication of left ventricular diastolic dysfunction in cryptogenic ischemic stroke". (2014) (0)
85 – Ventricular Tachycardia in Patients With Dilated Cardiomyopathy (2018) (0)
Psychiatrische Notfallaufnahmen und stationäre Aufenthalts- dauer vor und während der COVID-19-Pandemie in Deutschland Psychiatric Emergency Admissions and Inpatient Length of Stay Before and During the COVID-19 Pandemic in Germany (2022) (0)
[Diagnostic and therapeutic problems in idiopathic prolonged QT syndrome. A case report]. (1993) (0)
[Implantable loop recorder in atrial fibrillation and after catheter ablation]. (2016) (0)
Anticoagulation in special patient populations with atrial fibrillation (2021) (0)
[Problems with anti-arrhythmia therapy in atrial fibrillation]. (1994) (0)
Primary electrical disorders and arrhythmogenic right ventricular cardiomyopathy: new research insights with clinical implications. (2018) (0)
[Results of thrombolytic therapy in acute myocardial infarct]. (1988) (0)
Scientific papers: principles and scenarios of automated email routing and request-tracking: A field-study with 4 different systems (2002) (0)
Ultra-low-temperature cryoablation for ventricular tachycardia in non-ischemic cardiomyopathy – a case report (2023) (0)
Rapid Fire Abstract: Multimodality imaging valvular heart disease. (2016) (0)
The European Heart Rhythm Association: On the Move Towards the Future of Electrophysiology. (2016) (0)
[Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide]. (1988) (0)
Reperfusion arrhythmias: a myth? (1995) (0)
Development and Validation of a Multivariable Risk Prediction Model for Sudden Cardiac Death after Myocardial Infarction (PROFID Risk Model): Study Rationale, Design and Protocol (2021) (0)
A platform-independent datamining/quality-management-system with PHP3 and mySQL: a project study (2000) (0)
AB41-4: Occurrence of ischemic strokes during long-term follow-up after intraoperative radiofrequency catheter ablation of atrial fibrillation (2006) (0)
Dissociation of right and left AV conduction: What is the mechanism? (2016) (0)
176-27: Predictors and long-term rhythm outcome of early cardioversion failure after atrial fibrillation ablation (2016) (0)
Catheter-Mediated Radiofrequency Coagulation of Ventricular Myocardium (2009) (0)
Development of atrial fibrillation catheter ablation and ablation strategies (2018) (0)
University of Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation (2018) (0)
[Atrial fibrillation]. (2021) (0)
216-61: Echocardiographic predictors of ventricular arrhythmias in patients with left ventricular assist device: a large single-center study (2016) (0)
About Specific Targets and Collateral Damage. (2016) (0)
The implantable cardioverter defibrillator, conclusions on sudden cardiac death, and future perspective (2018) (0)
Expected and observed in‐hospital mortality in heart failure patients before and during the COVID‐19 pandemic: Introduction of the machine learning‐based standardized mortality ratio at Helios hospitals (2021) (0)
The European Heart Rhythm Association: A Myriad of Benefits and Privileges. (2016) (0)
Abstract 14729: Changes in Renal Function After Radiofrequency Catheter Ablation of Atrial Fibrillation Are Associated With CHA2DSs-Vasc Score: The Leipzig Heart Center AF Ablation Registry (2013) (0)
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: De ﬁ nition, characterisation, and clinical implication $ , $$ Journal of Arrhythmia (2016) (0)
Letter by Sepehri Shamloo et al Regarding Article, "Atrial Fibrillation Catheter Ablation Improves 1-Year Follow-Up Cognitive Function, Especially in Patients with Impaired Cognitive Function". (2019) (0)
Incidence and causes of in-hospital mortality in cardiac device-related infections (2020) (0)
A randomized trial of non-fasting vs. fasting for cardiac implantable electronic device procedures (Fast-CIED Study). (2022) (0)
Home-Monitoring Technology Suggests an Improvement in Survival in Heart Failure Patients (2013) (0)
Abstract 13840: Complications, Procedure-related Death, and In-hospital Mortality After Catheter Ablation for Ventricular Tachycardia in Ischemic and Non-ischemic Dilated Cardiomyopathy (2013) (0)
Cardiac tamponade complicating ventricular arrhythmia ablation: Real life data on incidence, management, and outcome (2022) (0)
CENTRAL RETINAL ARTERY OCCLUSION: META-ANALYSIS FOR THE RISK OF NEW ONSET ATRIAL FIBRILLATION AND STROKE (2023) (0)
Machine learning-derived prediction of in-hospital mortality in patients with severe acute respiratory infection: analysis of claims data from the German-wide Helios hospital network (2022) (0)
OP-EUPA180194 655..661 (2019) (0)
Biatrial volume ratio predicts low voltage areas in atrial fibrillation (2021) (0)
Visualisation of the individual left atrial-oesophageal relationship in order to prevent oesophagus perforation during AF ablation (2005) (0)
The End of a Never-Ending Story. (2019) (0)
69-07: Signal-Averaged Electrocardiography as a Noninvasive Tool for Evaluating the Outcomes after Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients with Ischemic Heart Disease: Reappraisal of an Old Tool (2016) (0)
OP-EHEA180178 2942..2955 (2018) (0)
Letter by Kosiuk et al Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])". (2017) (0)
Comprar Cardiac Mapping | John Gormley | 9781405175722 | Wiley (2009) (0)
Progressive angiogenesis and lone atrial fibrillation: The expression of VEGF, bFGF and AT2 in the fibrillating human atrium (2004) (0)
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? Reply. (2013) (0)
[Quality assurance in interventional electrophysiology (ablation, automatic defibrillators)]. (1994) (0)
[Cardiovascular magnetic resonance imaging in patients with cardiac devices : Useful tool or just artifacts?] (2022) (0)
Poster session Thursday 12 December - PM: 12/12/2013, 14:00-18:00 * Location: Poster area (2013) (0)
Electrophysiologic Effects, Clinical Efficacy and Antiarrhythmic and Proarrhythmic Effects of Sodium Channel Blockers in Patients with Ventricular Tachyarrhythmias (1995) (0)
KCNN3 VARIANT AND RISK OF ATRIAL FIBRILLATION RECURRENCE AFTER CATHETER ABLATION (2012) (0)
Abstract 2745: Electrical Coupling Index Guided Radiofrequency Ablation of the Pulmonary Veins (2009) (0)
SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results (2021) (0)
IMPACT OF LEFT ATRIAL APPENDAGE MORPHOLOGY ON PER-INTERVENTIONAL THROMBOEMBOLIC RISK DURING CATHETER ABLATION OF ATRIAL FIBRILLATION (2014) (0)
Abstract 18309: Familial Atrial Fibrillation - Common Atrial Fibrillation Susceptibility Alleles and Response to Catheter Ablation (2012) (0)
Cardiovascular magnetic resonance pulmonary perfusion for functional assessment of pulmonary vein stenosis. (2023) (0)
CONTACT FORCE BY DEFORMATION OF ABLATION CATHETERS: CAN WE PREDICT BY BENDING? (2021) (0)
Catheterinterventional redo procedures after previous intraoperative ablation of atrial fibrillation during cardiac surgery – a retrospective analysis (2012) (0)
Questionable levels of evidence in new atrial fibrillation guidelines? Reply. (2013) (0)
Predictors of major procedure-related complications in transvenous lead extraction (2020) (0)
176-24: Patterns of left atrial activation and evaluation of atrial dyssynchrony in patients with atrial fibrillation and normal controls: steps beyond the left atrial dimensions (2016) (0)
[High frequency current catheter ablation in ventricular tachycardia]. (1995) (0)
Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale. (2021) (0)
Catheter Ablation of Atrial Fibrillation as Chronic Kidney Disease Treatment (2014) (0)
Correction to: Arginine derivatives in atrial fibrillation progression phenotypes (2021) (0)
Catheter ablation of atrial fibrillation and thromboembolic risk. (2015) (0)
Validation of the VT‐LVAD score for prediction of late VAs in LVAD recipients (2020) (0)
Pseudo repetitive non-reentrant ventriculoatrial synchrony: current challenges. (2023) (0)
[Cardiovascular medicine-cardiac arrhythmias]. (2022) (0)
Left atrial appendectomy and maze. Authors' reply (2003) (0)
Transvenous extraction of adherent electronic device leads using a lead locking stylet (Spectranetics LLD) – experience of 202 applications (2007) (0)
Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead? (2020) (0)
Running title: Shoemaker et al.; Genetic Variants and Response to AF Ablation (2017) (0)
Abstract P172: Circulating Heat Shock Protein 70 and Antiheat Shock Protein 70 Antibodies in Atrial Fibrillation: Relation with Atrial Fibrillation Type and Response to Catheter Ablation (2011) (0)
A Novel Method for Catheter – Tissue Contact Assessment During Atrial Fibrillation Ablation : The Electrical Coupling Index (2011) (0)
Rotors in human AF: an ongoing discussion (2015) (0)
Evaluation of the Safety and Efficacy of the OPTIMIZER™ II and III Systems with Active Fixation Leads in Subjects with HF Resulting from Systolic Dysfunction: FIX-CHF-4 (2006) (0)
Multi‐modality and Multi‐dimensional Mapping: How Far Do We Need To Go? (2012) (0)
Anisotropic conduction characteristics in chronic myocardial infarction with morphologically distinct epicardial patterns — Implications for arrhythmogenesis (1993) (0)
Assessing of Organic Mitral Regurgitation by Real Time Echocardiographic 3D Proximal Isovelocity Surface Area (3D-PISA): A Cardiovascular Magnetic Resonance Validation (2020) (0)
Antikoagulation nach Kardioversion (2012) (0)
Outcomes following cardiac sympathetic denervation in patients with structural heart disease and refractory ventricular arrhythmia. (2022) (0)
Arginine derivatives in atrial fibrillation progression phenotypes (2020) (0)
Response of circulating heat shock protein 70 and anti-heat shock protein 70 antibodies to catheter ablation of atrial fibrillation (2013) (0)
[Epicardial approach during ablation of ventricular tachycardia in patients with ischaemic cardiomyopathy - utility and safety of the method]. (2012) (0)
[What are the explanations for occasionally observed normalization of the electrocardiographic signal in WPW syndrome?]. (1992) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gerhardt Hindricks?

Gerhardt Hindricks is affiliated with the following schools:

Leipzig University
Faculdade de Ciências Médicas de Minas Gerais
Aarhus University

Gerhardt Hindricks's Academic­Influence.com Rankings

Gerhardt Hindricks's Degrees

Why Is Gerhardt Hindricks Influential?

Gerhardt Hindricks's Published Works

Published Works

What Schools Are Affiliated With Gerhardt Hindricks?

Gerhardt Hindricks's AcademicInfluence.com Rankings